As of 8:10 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).
Audit Committee* - isis pharmaceuticals inc (ISIS)
Nominating Committee* - isis pharmaceuticals inc (ISIS)
|Name (Connections)||Board Relationships||Title||Key Developments|
|Joseph Wender || 138 Relationships||Director, Chairman of Audit Committee, Member of Nominating, Governance & Review Committee and Member of Compensation Committee||Isis Pharmaceuticals, Inc. Appoints Sarah Boyce as Chief Business Officer|
|Spencer Berthelsen M.D.|| 7 Relationships||Director, Chairman of Compensation Committee, Chairman of Nominating, Governance & Review Committee and Member of Science/Medical Committee||Isis Pharmaceuticals, Inc. Names Joseph Loscalzo to the Board of Directors|
*Data is at least as current as the most recent Definitive Proxy.
Sponsored Financial Commentaries